Skip to content
- aflibercept (Zaltrap®)
- axitinib (Inlyta®)
- bevacizumab (Avastin®)
- cabozantinib (Cabometyx®)
- lenvatinib (Lenvima®)
- pazopanib (Votrient®)
- regorafenib (Stivarga®)
- sorafenib (Nexavar®)
- sunitinib (Sutent®)
- vandetanib (Caprelsa®)
- afatinib (Giotrif®)
- cetuximab (Erbitux®)
- erlotinib (Tarceva®)
- panitumumab (Vectibix®)
- lapatinib (Tyverb®)
- T-DM1/ trastuzumab emtansine (Kadcyla®)
- trastuzumab (Herceptin®)
- dabrafenib (Tafinlar®)
- rucaparib (Rubraca®)
- encorafenib (Braftovi®)
- vemurafenib (Zelboraf®)
- binimetinib (Mektovi®)
- trametinib (Mekinist®)